13 November 2014
Updates on Lung Cancer
With the assistance of the APSR Lung Cancer Assembly, and the hosted by the Indonesian Society of Respirology, this pre-congress ESAP took place in Bali, Indonesia, as a post-graduate course prior to the 19th Congress of the APSR.
Lung cancer is the leading cause of mortality of all cancer in the world. As two-thirds of smoking prevalence in the world is in the Asia-Pacific region, especially China, India and Indonesia, the prevalence of lung cancer in the region is increasing. The prevalence of lung cancer for nonsmokers and females is also increasing.
Pulmonologists and respiratory physicians play a key role in the diagnosis, staging and treatment of lung cancer. They also lead and participate in multidisciplinary efforts for lung cancer as well as managing comorbidities, provide medical treatment (chemotherapy and biological therapy), endobronchial treatment, general supportive care, and end-of-life care.
As the advancement of lung cancer biology and treatments is challenging, it is important to educate pulmonologists in the field. This ESAP presented updates on lung cancer biology, diagnosis and treatment.
|Chair:||Dr Kwun Fong|
University of Queensland
Thoracic Research Centre at The Prince Charles Hospital
|Co-chair: ||Dr Anwar Jusuf|
Department of Pulmonology and Respiratory Medicine
Faculty of Medicine,
University of Indonesia Persahabatan Hospital,
- Dr E Hiyama (Japan)
- Dr T Kikuchi (Japan)
- Dr K Kishi (Japan)
- Dr C Bai (China)
- Dr D C L Lam (Hong Kong)
- Dr B Robinson (Australia)
- Dr C K Liam (Malaysia)
- Dr K Hagiwara (Japan).
The event was well attended, including respiratory physicians, healthcare professionals and researchers from Australia, China, Hong Kong, Indonesia, Japan, Korea, Malaysia, Philipines, Singapore, and United Arab Emirates.